Economic Impact of Reducing Reexcision Rates after Breast-Conserving Surgery in a Large, Integrated Health System.

Jeffery M ChakedisAnnie TangAlison SavitzLiisa L LyonPatricia E PalaciosBrooke VuongMaihgan A KavanaghGillian E KuehnerSharon B Changnull null

Published in: Annals of surgical oncology (2022)

Reexcision after BCS represents 39% of direct OR costs and 14% of OR time in our healthcare system. Modest improvements in surgeon reexcision rates may lead to significant economic and OR time savings.

Keyphrases

minimally invasive
coronary artery bypass
robot assisted
squamous cell carcinoma
radiation therapy
acute coronary syndrome
atrial fibrillation
percutaneous coronary intervention